Skip to content
10-K

Annual Report

CORMEDIX INC. CRMD

0001213900-26-023889

← back to feed
Filed
Mar 5, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 2, 2026 79.05M sh
Shares Diluted FY 2025 · Dec 31, 2025 80.31K sh
Shares Diluted restated FY 2025 · Dec 31, 2024 58.87K sh
Capex FY 2025 · Dec 31, 2025 $2.26M
Capex restated FY 2025 · Dec 31, 2024 $116K
Operating Cash Flow FY 2025 · Dec 31, 2025 $175.05M
Operating Cash Flow restated FY 2025 · Dec 31, 2024 −$50.62M
Short Term Investments FY 2025 · Dec 31, 2025 $3.69M
Short Term Investments restated FY 2025 · Dec 31, 2024 $11.04M
Cash And Equivalents FY 2025 · Dec 31, 2025 $144.84M
Cash And Equivalents restated FY 2025 · Dec 31, 2024 $40.65M
Stockholders Equity FY 2025 · Dec 31, 2025 $405.31M
Stockholders Equity restated FY 2025 · Dec 31, 2024 $84.66M
Stockholders Equity restated FY 2025 · Dec 31, 2023 $70.14M
Current Liabilities FY 2025 · Dec 31, 2025 $174.27M
Current Liabilities restated FY 2025 · Dec 31, 2024 $33.84M
Total Liabilities FY 2025 · Dec 31, 2025 $420.84M
Total Liabilities restated FY 2025 · Dec 31, 2024 $34.19M
Current Assets FY 2025 · Dec 31, 2025 $367.05M
Current Assets restated FY 2025 · Dec 31, 2024 $114.58M
Total Assets FY 2025 · Dec 31, 2025 $826.14M
Total Assets restated FY 2025 · Dec 31, 2024 $118.85M
Eps Diluted FY 2025 · Dec 31, 2025 $2.04
Eps Diluted FY 2025 · Dec 31, 2024 −$0.30
Eps Basic FY 2025 · Dec 31, 2025 $2.25
Eps Basic FY 2025 · Dec 31, 2024 −$0.30
Rd Expense FY 2025 · Dec 31, 2025 $19.33M
Rd Expense restated FY 2025 · Dec 31, 2024 $3.94M
Net Income FY 2025 · Dec 31, 2025 $163.06M
Net Income restated FY 2025 · Dec 31, 2024 −$17.93M
Operating Income FY 2025 · Dec 31, 2025 $150.14M
Operating Income restated FY 2025 · Dec 31, 2024 −$22.36M
Gross Profit FY 2025 · Dec 31, 2025 $275.75M
Gross Profit restated FY 2025 · Dec 31, 2024 $40.28M
Cost Of Revenue FY 2025 · Dec 31, 2025 $22.09M
Cost Of Revenue restated FY 2025 · Dec 31, 2024 $3.03M